Difference between revisions of "Mapatumumab (HGS-ETR1)"
Jump to navigation
Jump to search
(Created page with "=Mechanism of action= Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) Category:Drug index [[Categ...") |
m |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | =Mechanism of action= | + | ==Mechanism of action== |
Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) | Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) | ||
| − | [[Category: | + | ==Also known as== |
| + | *'''Code name:''' HGS-ETR1 | ||
| + | |||
| + | [[Category:Drugs]] | ||
| + | |||
| + | [[Category:Intravenous medications]] | ||
| − | |||
[[Category:Anti-TRAIL-R1 antibodies]] | [[Category:Anti-TRAIL-R1 antibodies]] | ||
| − | [[Category:Investigational]] | + | [[Category:Investigational drugs]] |
Latest revision as of 13:56, 16 December 2020
Mechanism of action
Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1)
Also known as
- Code name: HGS-ETR1